((1-(phenylmethyl)-1h-indazol-3-yl)oxy)acetic acid - CAS 20187-55-7
Category:
Main Product
Product Name:
((1-(phenylmethyl)-1h-indazol-3-yl)oxy)acetic acid
Catalog Number:
20187-55-7
Synonyms:
bendazac; 20187-55-7; Bindazac; Bendazolicacid; Zildasac; 2-(1-Benzyl-1H-indazol-3-yloxy)aceticAcid
CAS Number:
20187-55-7
Molecular Weight:
282.3
Molecular Formula:
C16H14N2O3
Quantity:
Data not available, please inquire.
COA:
Inquire
MSDS:
Inquire
Canonical SMILES:
C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=N2)OCC(=O)O
InChI:
InChI=1S/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20)
InChIKey:
BYFMCKSPFYVMOU-UHFFFAOYSA-N
Chemical Structure
CAS 20187-55-7 ((1-(phenylmethyl)-1h-indazol-3-yl)oxy)acetic acid

Reference Reading


1.Racemization of lens crystalline constituents in UV-induced cataract evaluated by chiral GC/MS spectroscopy.
Jung WT1, Rho SH, Park WC. Ophthalmic Res. 1996;28 Suppl 2:26-31.
The racemization of amino acids is hypothesized to cause cataract by disrupting the crystalline's tertiary structure, which, in turn, alters the optical characteristics of the lens. To better understand the role of these modifications in cataractogenesis, the changes in stereoisomer ratio of amino acids from lens crystalline by UV-B-induced cataract in animal models were studied using chiral separation gas chromatography-single quadrupole mass spectroscopy. The anticataract action of a compound, ([1-(phenylmethyl)-1H-indazol-3-yl]oxy)acetic acid lysinate, was also evaluated by this method.